Source link : https://www.mondialnews.com/2026/07/12/uk-us-pharma-deal-could-lead-to-nearly-230000-unnecessary-deaths-in-england-analysis-warns/
A recent analysis has raised serious concerns over the proposed pharmaceutical agreement between the United Kingdom and the United States, warning that the deal could result in nearly 230,000 avoidable deaths in England. Critics argue that changes to drug pricing and regulatory standards embedded in the agreement may limit access to affordable medicines, disproportionately impacting vulnerable patients. As negotiations continue, health experts and advocacy groups are calling for urgent scrutiny to prevent potentially devastating consequences for the nation’s healthcare system.
UK US Pharma Deal Raises Serious Concerns Over Patient Safety in England
Recent analysis has revealed alarming projections linked to a new pharmaceutical agreement between the UK and the US, spotlighting a potential public health crisis in England. Experts warn that changes proposed in drug pricing and access negotiations could restrict availability of essential medicines, ultimately resulting in nearly 230,000 avoidable deaths over the coming years. This grim estimate underscores the gravity of policy shifts that might prioritize commercial interests over patient welfare, prompting calls for urgent reassessment of the deal’s implications on the National Health Service (NHS).
Critics highlight several key concerns that amplify the risks posed by the deal:
- Delayed introduction of affordable generic drugs, reducing treatment options for chronic and life-threatening illnesses.
- Increased…
—-
Author : Sophia Davis
Publish date : 2026-07-12 07:02:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8